AU Stock MarketDetailed Quotes

AGN Argenica Therapeutics Ltd

Watchlist
  • 0.860
  • +0.010+1.18%
20min DelayMarket Closed Jul 18 15:57 AET
106.38MMarket Cap-15636P/E (Static)

Argenica Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense
52.24%6.62M
228.24%4.35M
1.33M
Selling and administrative expenses
20.90%2.11M
121.37%1.75M
--789.66K
-General and administrative expense
20.90%2.11M
121.37%1.75M
--789.66K
Research and development costs
72.60%4.31M
499.94%2.5M
--416.05K
Other operating expenses
89.31%203.35K
-10.49%107.41K
--120K
Operating profit
-52.24%-6.62M
-228.24%-4.35M
-1.33M
Net non-operating interest income (expenses)
3,464.03%59.95K
824.18%1.68K
182
Non-operating interest income
2,335.98%61K
1,139.60%2.5K
--202
Non-operating interest expense
27.74%1.05K
4,010.00%822
--20
Other net income (expenses)
575.38%1.75M
-12.49%259.1K
296.08K
Other non-operating income (expenses)
575.38%1.75M
-12.49%259.1K
--296.08K
Income before tax
-17.71%-4.82M
-297.37%-4.09M
-1.03M
Income tax
0
0
54
Earnings from equity interest net of tax
Net income
-17.71%-4.82M
-297.35%-4.09M
-1.03M
Net income continuous operations
-17.71%-4.82M
-297.35%-4.09M
---1.03M
Noncontrolling interests
Net income attributable to the company
-17.71%-4.82M
-297.35%-4.09M
-1.03M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-17.71%-4.82M
-297.35%-4.09M
-1.03M
Diluted earnings per share
0.00%-0.055
-89.66%-0.055
-0.029
Basic earnings per share
0.00%-0.055
-89.66%-0.055
-0.029
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense 52.24%6.62M228.24%4.35M1.33M
Selling and administrative expenses 20.90%2.11M121.37%1.75M--789.66K
-General and administrative expense 20.90%2.11M121.37%1.75M--789.66K
Research and development costs 72.60%4.31M499.94%2.5M--416.05K
Other operating expenses 89.31%203.35K-10.49%107.41K--120K
Operating profit -52.24%-6.62M-228.24%-4.35M-1.33M
Net non-operating interest income (expenses) 3,464.03%59.95K824.18%1.68K182
Non-operating interest income 2,335.98%61K1,139.60%2.5K--202
Non-operating interest expense 27.74%1.05K4,010.00%822--20
Other net income (expenses) 575.38%1.75M-12.49%259.1K296.08K
Other non-operating income (expenses) 575.38%1.75M-12.49%259.1K--296.08K
Income before tax -17.71%-4.82M-297.37%-4.09M-1.03M
Income tax 0054
Earnings from equity interest net of tax
Net income -17.71%-4.82M-297.35%-4.09M-1.03M
Net income continuous operations -17.71%-4.82M-297.35%-4.09M---1.03M
Noncontrolling interests
Net income attributable to the company -17.71%-4.82M-297.35%-4.09M-1.03M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -17.71%-4.82M-297.35%-4.09M-1.03M
Diluted earnings per share 0.00%-0.055-89.66%-0.055-0.029
Basic earnings per share 0.00%-0.055-89.66%-0.055-0.029
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg